Stryker Pre-Tax Income 2010-2024 | SYK
Stryker annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Stryker pre-tax income for the quarter ending December 31, 2024 was $0.528B, a 56.93% decline year-over-year.
- Stryker pre-tax income for the twelve months ending December 31, 2024 was $3.492B, a 4.93% decline year-over-year.
- Stryker annual pre-tax income for 2024 was $3.492B, a 4.93% decline from 2023.
- Stryker annual pre-tax income for 2023 was $3.673B, a 36.9% increase from 2022.
- Stryker annual pre-tax income for 2022 was $2.683B, a 17.62% increase from 2021.
| Stryker Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $3,492 |
| 2023 | $3,673 |
| 2022 | $2,683 |
| 2021 | $2,281 |
| 2020 | $1,954 |
| 2019 | $2,562 |
| 2018 | $2,356 |
| 2017 | $2,063 |
| 2016 | $1,921 |
| 2015 | $1,735 |
| 2014 | $1,160 |
| 2013 | $1,212 |
| 2012 | $1,705 |
| 2011 | $1,686 |
| 2010 | $1,729 |
| 2009 | $1,624 |
| Stryker Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $528 |
| 2024-09-30 | $1,043 |
| 2024-06-30 | $998 |
| 2024-03-31 | $923 |
| 2023-12-31 | $1,226 |
| 2023-09-30 | $869 |
| 2023-06-30 | $899 |
| 2023-03-31 | $679 |
| 2022-12-31 | $761 |
| 2022-09-30 | $816 |
| 2022-06-30 | $720 |
| 2022-03-31 | $386 |
| 2021-12-31 | $757 |
| 2021-09-30 | $495 |
| 2021-06-30 | $662 |
| 2021-03-31 | $367 |
| 2020-12-31 | $671 |
| 2020-09-30 | $780 |
| 2020-06-30 | $-87 |
| 2020-03-31 | $590 |
| 2019-12-31 | $936 |
| 2019-09-30 | $581 |
| 2019-06-30 | $565 |
| 2019-03-31 | $480 |
| 2018-12-31 | $657 |
| 2018-09-30 | $534 |
| 2018-06-30 | $623 |
| 2018-03-31 | $542 |
| 2017-12-31 | $649 |
| 2017-09-30 | $471 |
| 2017-06-30 | $444 |
| 2017-03-31 | $499 |
| 2016-12-31 | $588 |
| 2016-09-30 | $419 |
| 2016-06-30 | $433 |
| 2016-03-31 | $481 |
| 2015-12-31 | $612 |
| 2015-09-30 | $345 |
| 2015-06-30 | $401 |
| 2015-03-31 | $377 |
| 2014-12-31 | $461 |
| 2014-09-30 | $425 |
| 2014-06-30 | $167 |
| 2014-03-31 | $107 |
| 2013-12-31 | $431 |
| 2013-09-30 | $137 |
| 2013-06-30 | $269 |
| 2013-03-31 | $375 |
| 2012-12-31 | $358 |
| 2012-09-30 | $444 |
| 2012-06-30 | $435 |
| 2012-03-31 | $468 |
| 2011-12-31 | $433 |
| 2011-09-30 | $431 |
| 2011-06-30 | $411 |
| 2011-03-31 | $411 |
| 2010-12-31 | $379 |
| 2010-09-30 | $462 |
| 2010-06-30 | $443 |
| 2010-03-31 | $446 |
| 2009-12-31 | $523 |
| 2009-09-30 | $314 |
| 2009-06-30 | $400 |
| 2009-03-31 | $386 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $150.988B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |